Zhao Haifeng

Learn More
Chemoresistance remains a significant challenge in chronic myelogenous leukemia (CML) management, which is one of the most critical prognostic factors. Elucidation the molecular mechanisms underlying the resistance to chemoresistance may lead to better clinical outcomes. In order to identify potential protein targets involved in the drug-resistant phenotype(More)
  • 1